Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immutep (IMMP)
NASDAQ:IMMP
Immutep (IMMP) Stock Price & Analysis
548 Followers
IMMP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.47 - $3.90
Previous Close$1.92
Volume51.21K
Average Volume (3M)160.73K
Market Cap
$215.65M
Enterprise Value$172.68M
Total Cash (Recent Filing)AU$68.38M
Total Debt (Recent Filing)AU$952.66K
Price to Earnings (P/E)-6.4
Beta1.48
Next Earnings
Feb 22, 2024EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding86,623,982
10 Day Avg. Volume90,136
30 Day Avg. Volume160,734
Standard Deviation0.22
R-Squared0.33
Alpha0.00013
Financial Highlights & Ratios
Price to Book (P/B)2.53
Price to Sales (P/S)24.61
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$7.00Price Target Upside264.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Immutep News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMMP FAQ
What was Immutep’s price range in the past 12 months?
Immutep lowest stock price was $1.47 and its highest was $3.90 in the past 12 months.
What is Immutep’s market cap?
Currently, no data Available
When is Immutep’s upcoming earnings report date?
Immutep’s upcoming earnings report date is Feb 22, 2024 which is in 147 days.
How were Immutep’s earnings last quarter?
Immutep released its earnings results on Aug 29, 2023. The company reported -$0.136 earnings per share for the quarter, beating the consensus estimate of -$0.153 by $0.017.
Is Immutep overvalued?
According to Wall Street analysts Immutep’s price is currently Undervalued.
Does Immutep pay dividends?
Immutep does not currently pay dividends.
What is Immutep’s EPS estimate?
Immutep’s EPS estimate is -$0.18.
How many shares outstanding does Immutep have?
Immutep has 118,730,620 shares outstanding.
What happened to Immutep’s price movement after its last earnings report?
Immutep reported an EPS of -$0.136 in its last earnings report, beating expectations of -$0.153. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Immutep?
Among the largest hedge funds holding Immutep’s share is Oracle Investment Management Inc. It holds Immutep’s shares valued at 2M.
---
Immutep Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (264.58% Upside)
$7.00 (264.58% Upside)
Blogger Sentiment
Bullish
IMMP Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 456.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.25%
12-Months-Change
Fundamentals
Return on Equity
-34.51%
Trailing 12-Months
Asset Growth
39.70%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Immutep
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
---
Top 5 ETFs holding IMMP
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold IMMP. The ETFs are listed according to market value of IMMP within the ETF
---